Is Healthy Life overvalued or undervalued?
2025-11-19 08:10:01As of 18 November 2025, the valuation grade for Healthy Life has moved from very attractive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.90, an EV to EBITDA of 16.07, and a ROCE of 10.96%. In comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 53.39 and Nestle India's 81.48, both of which are categorized as very expensive. Despite this, Healthy Life's current valuation does not justify its price, especially given its recent stock performance, which has seen a drastic decline of 72.29% year-to-date, contrasting sharply with the Sensex's 8.36% gain in the same period....
Read MoreHow has been the historical performance of Healthy Life?
2025-11-15 00:26:58Answer: The historical performance of Healthy Life shows significant growth over the years, particularly in net sales and profitability. Breakdown: Healthy Life's net sales have increased from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25. The company's total expenditure also grew, from 32.78 Cr in Mar'22 to 166.98 Cr in Mar'25, but the operating profit (PBDIT) improved from 1.18 Cr to 4.89 Cr during the same period, indicating enhanced operational efficiency. Profit before tax rose from 1.12 Cr in Mar'22 to 4.35 Cr in Mar'25, while profit after tax increased from 0.83 Cr to 3.26 Cr, showcasing a consistent improvement in profitability. The earnings per share (EPS) fluctuated, reaching 0.83 in Mar'25, down from 1.14 in Mar'24. On the balance sheet, total assets grew...
Read MoreWhen is the next results date for Healthy Life?
2025-11-11 23:20:31The next results date for Healthy Life is scheduled for 14 November 2025....
Read MoreIs Healthy Life overvalued or undervalued?
2025-11-10 08:12:58As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in perception regarding its market value. The company is currently assessed as undervalued, particularly when considering its PE ratio of 26.24, EV to EBITDA of 17.44, and ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics stand out; for instance, Hindustan Unilever has a PE ratio of 53.63 and Nestle India has a PE of 81.21, both categorized as very expensive. Despite the recent downturn in stock performance with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's attractive valuation suggests potential for recovery. The company's EV to Sales ratio of 0.50 further supports the argument for undervaluation, especially when juxtaposed against its peers, many of which exhibit significantly higher valuation multiples....
Read MoreIs Healthy Life overvalued or undervalued?
2025-11-09 08:11:12As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, with a PE ratio of 26.24, an EV to EBITDA ratio of 17.44, and a ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics are significantly lower; for instance, Hindustan Unilever has a PE ratio of 53.63, while Nestle India stands at 81.21. Despite the recent decline in stock performance, with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's current valuation appears attractive relative to its peers in the FMCG sector. The company's EV to Sales ratio of 0.50 further supports the notion of undervaluation, especially when juxtaposed against competitors like Britannia Industries, which has a much higher valuation. Overall, Healthy Life presents a compelling investment oppo...
Read MoreIs Healthy Life overvalued or undervalued?
2025-11-08 08:11:04As of 7 November 2025, the valuation grade for Healthy Life has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as overvalued. Key ratios include a PE ratio of 26.24, an EV to EBITDA of 17.44, and a ROCE of 13.87%. In comparison to its peers, Healthy Life's PE ratio is significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both categorized as very expensive. Despite this, the company's valuation appears stretched given its current performance and the broader market context. Notably, Healthy Life has underperformed the Sensex over the past year, with a return of -48.38% compared to the Sensex's 4.62%, reinforcing the notion of its overvaluation....
Read MoreWhy is Healthy Life falling/rising?
2025-11-05 00:11:47As of 04-Nov, Healthy Life Agritec Ltd's stock price is currently at 16.64, reflecting an increase of 0.79 or 4.98%. The stock has shown a positive trend recently, gaining for three consecutive days and achieving a total return of 14.68% during this period. Additionally, it has outperformed its sector by 5.2%. Despite a significant decline of 67.96% year-to-date and 47.37% over the past year, the stock's recent performance indicates a rebound, supported by a notable increase in delivery volume, which rose by 35.42% compared to the five-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's movement. Broader Market Context: In the short term, Healthy Life Agritec Ltd has outperformed the Sensex, which has declined by 1.38% over the past week while the stock itself has gained 3.55%. This contrast highlights the stock's relat...
Read MoreWhy is Healthy Life falling/rising?
2025-10-29 01:55:05As of 28-Oct, Healthy Life Agritec Ltd's stock price is currently at 16.07, reflecting a decline of 0.84, or 4.97%. The stock has been underperforming significantly, with a consecutive fall over the last four days and a total return of -14.61% in the past week. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, while there has been a slight increase in delivery volume, the overall performance today has underperformed the sector by 4.42%. The stock's year-to-date performance shows a drastic decline of 69.06%, further emphasizing its struggles compared to the benchmark. In the broader market context, the Sensex has shown a modest gain of 0.24% over the past week, contrasting sharply with Healthy Life's significant decline. This stark difference highlights the stock's poor performance relative to the market. Over the last month, ...
Read MoreWhy is Healthy Life falling/rising?
2025-10-28 23:01:29As of 27-Oct, Healthy Life Agritec Ltd is experiencing a decline in its stock price, currently at 16.91, which represents a decrease of 0.89 or 5.0%. The stock has been underperforming significantly, having fallen consecutively for the last three days, resulting in a total decline of 10.15% during this period. Additionally, it is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 5.74%, and its performance over the past month shows a staggering drop of 27.05%. The year-to-date performance is also concerning, with a decline of 67.44%. While there has been a notable increase in investor participation, with delivery volume rising by 64.56% against the five-day average, the overall sentiment remains negative, and no positive factors are available to counterbalance the stock's recent poor performance. In the broader market context, the Sensex has sh...
Read MoreBoard Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015
14-Nov-2025 | Source : BSESubmission of Unaudited Consolidated and Standalone Financial Results for the half- year ended 30 September 2025 pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015
Submission Of Unaudited Consolidated And Standalone Financial Results For The Half- Year Ended 30 September 2025 Pursuant To Regulation 33 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015
14-Nov-2025 | Source : BSEApproval of Unaudited Financial Results for the period ended 30 September 2025.
Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015.
10-Nov-2025 | Source : BSEHealthy Life Agritec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the half-year ended on 30 September 2025 and any other matter with the permission of the Chai.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Healthy Life Agritec Ltd has announced 1:1 rights issue, ex-date: 26 Sep 25






